Nephros Inc (NEPH) · Oct 13, 2026 · Other events

Nephros annual meeting set for Nov. 25; proxy deadline reset

Annual meeting scheduled — November 25 meeting; October 23 proposal deadline

Nephros scheduled its 2026 annual meeting for November 25 and set October 23 deadlines for proposals and alternative director nominees.

Nephros is a growing water-filtration company serving medical and commercial markets, with recent momentum in recurring programmatic revenue, services, and newer filtration applications. Its latest reported quarter reached record revenue of $6 million, while management highlighted expansion across medical and commercial water-safety products.

This filing does not change that operating story. It sets the 2026 annual meeting for November 25, 2026, more than five months after the prior annual meeting, and confirms the meeting will be held virtually.

The only practical significance is procedural: shareholder deadlines were reset. Proposals for inclusion in the proxy and notices supporting alternative director nominees must arrive by October 23, 2026. 〔0〕 The delayed meeting date reflects that it is more than 30 days beyond the anniversary of the June 16, 2025 meeting, rather than signaling a disclosed strategic or governance dispute. 〔1〕

Bottom line: This is routine shareholder-meeting housekeeping, not a new business catalyst. It matters mainly because October 23 is the deadline for any shareholder challenge or proposal to enter the proxy process; otherwise, the filing leaves Nephros’s growth narrative unchanged.

What to watch next

Definitive proxy statement and November 25 shareholder meeting

Original filing on SEC EDGAR

More Nephros Inc news

Nephros annual meeting set for Nov. 25; proxy deadline reset | NEPH Stock News
AllSight

Breaking down Wall Street's
information edge.

A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.

—
8-K events this week
—
filings analyzed in total
live · updated 30s ago
Live events · whole market · · --:--:-- ET
AllSight read
Straight from the 8-K
Verbatim from the filing AllSight decoded — highlighted above. Open on SEC EDGAR ↗
Limited-time offerFree 14-day Pro trial
AllSight

Sign in to AllSight

  • Follow any company — we email you the moment it files, free!
  • Your watchlist saved to your account, on every device — free!

by Signing in NOW, claim your FREE 14-day Pro trial!

No password. We email you a 6-digit code. By continuing you agree to our Terms & Privacy.
AllSight · Live plain-English 8-K decodes across the whole US market · Not investment advice.